ADAR and chronic myelogenous leukemia, BCR-ABL1 positive: Among them, the upregulation of ADAR1 is closely related to the occurrence, development and prognosis of cancer, including breast cancer, liver cancer, lung cancer, esophageal cancer, prostate cancer, chronic myeloid leukemia and multiple myeloma [106–110].